Rhett Wilkerson: Prior Authorization and Patient Access

Rhett Wilkerson, associate director of patient financial services, Florida Cancer Specialists, discusses how utilization management strategies impact patient access to biologics.


Yes, absolutely. So that's something that we work really hard with our utilization management team on we want to make sure that they have all the information available, because they really are kind of clicking those clinical boxes that says whether something should or shouldn't be supported.

So when they're when they're putting in that prior authorization information that they have everything they need to make the most appropriate selections, so that then there's less of a holdup, or denials, or things that have to go to peer-to-peer. We want it to be as smooth of a process as possible.

Related Videos
Michael Kleinrock
Ian Henshaw
Ian Henshaw
Ryan Haumschild, PharmD
John Gabrielson
Ryan Haumschild, PharmD, MS, MBA
Ryan Haumdschild, PharmD
banner for the ophthalmology linkedin live event sponsored by the samsung bioepis in partnership with the center for biosimilars
Ryan Haumschild, PharmD
Julie Reed
Related Content
© 2023 MJH Life Sciences

All rights reserved.